US5334534AExpiredUtility
Enzymatic preparation of optically active propanolol and β-adrenergic blockers using esterase
Est. expiryApr 15, 2012(expired)· nominal 20-yr term from priority
Inventors:Ching-Shih Chen
C12P 41/004C12P 13/02
51
PatentIndex Score
4
Cited by
7
References
2
Claims
Abstract
A computer modeling approach is taken to delineate the structural requirements of substrate molecules for biocatalytic turnover and enantioselective discrimination. This leads to an efficient enzymatic preparation of optically active propranolol. The acyl-sustituents on the alcohol and the secondary amine of propranolol play crucial roles in controlling the catalysis and enantiospecificity, respectively, of the enzymatic hydrolysis.
Claims
exact text as granted — not AI-modifiedHaving described my invention, what I now claim is:
1. A method for the synthesis of an enzymatic optically active propranolol which comprises: effecting an enzyme mediated enantioselective hydrolysis on a substrate of the formula: ##STR4## wherein the hydrolytic enzyme is cholesterol esterase, pig liver esterase or porcine pancrease esterase to form the corresponding (R) and (S) enantiomers; separating the diasteroisomers; and recovering the separated diasteroisomers.
2. The method of claim 1 which includes: converting the separated (S) enantiomer to ##STR5##Join the waitlist — get patent alerts
Track US5334534A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.